All Updates

All Updates

icon
Filter
Product updates
ConcertAI launches predictive and GenAI solutions for oncology research
AI Drug Discovery
May 31, 2024
This week:
Funding
GrayMatter Robotics raises USD 45 million in Series B funding to accelerate AI-powered robotics solutions
Smart Factory
Yesterday
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Logistics Tech
Yesterday
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Smart Factory
Yesterday
Funding
FairNow raises USD 3.5 million to advance AI governance solutions
Generative AI Infrastructure
Yesterday
Partnerships
Gravitics develops testing gauntlet for larger spacecraft in collaboration with NASA
Space Travel and Exploration Tech
Yesterday
M&A
knownwell acquires Alfie Health to integrate AI in primary and obesity care services
Telehealth
Yesterday
Funding
Pomelo Care raises USD 46 million in Series B funding to expand virtual maternal care
Telehealth
Yesterday
Funding
Isar Aerospace raises EUR 65 million, backed by NATO Innovation Fund
Space Travel and Exploration Tech
Yesterday
Product updates
Beyond Meat releases new Beyond Sausage, expanding its Beyond IV product line
Plant-based Meat
Yesterday
Product updates
Funding
SurrealDB raises USD 20 million in Series A; launches beta version of Surreal Cloud
Data Infrastructure & Analytics
Yesterday
AI Drug Discovery

AI Drug Discovery

May 31, 2024

ConcertAI launches predictive and GenAI solutions for oncology research

Product updates

  • AI-powered health and life sciences firm ConcertAI has unveiled its new predictive and GenAI solutions, expansions in partnerships, and a clinical oncology suite designed to enhance research capabilities and support complex clinical study workflows. These solutions aim to provide researchers with enhanced in-depth data analysis facilities, contributing to the creation of new care strategies to improve patient outcomes.

  • The company’s new GenAI solutions include 1) CARA AI, a comprehensive multi-modal data management platform designed to advance research across multiple fields, support collaborations, and manage multi-modal real-world data, and 2) TriaLinQ, a clinical trial screening system (as part of ConcertAI’s oncology quality management platform SmartLinQ) capable of screening 3x more patients than electronic medical records (EMR)-based screening.

  • The Massachusetts-based company offers an oncology-focused Saas platform that incorporates real-world data (RWD) to support drug developers and pharmaceutical companies in expediting drug discovery and development. It reportedly maintains the largest oncology database in the industry, with data gathered from various sources, including the FDA. It also offers clinical trial technology support platforms that assist with clinical trial management specializing in solutions for oncology-related trials.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.